FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308303217> ?p ?o ?g. }

• W4308303217 abstract "Abstract Background Endometrial adenocarcinoma (EC) is the fifth most common cancer in women worldwide, standard treatment for EC includes hysterectomy, but it results in the loss of reproductive function. Thus, conservative treatment for these patients is strongly demanded, progestin therapy is widely accepted as the main fertility-sparing treatment for young women with endometrial hyperplasia with atypia (EHA) and well-differentiated endometrioid endometrial cancer. This trial will investigate the effectiveness of conservative treatment for obese women with early-stage EC. Method and design This will be an open-label, 2-armed, randomized, phase-II single-center trial of LNG-IUD plus metformin or megestrol acetate (MA) plus metformin. A total of 88 participants will be randomly assigned into 2 treatment arms in a 1:1 ratio. Clinical, laboratory, ultrasound and radiology data, will be collected at baseline, and then at 3, 6, 9, 12, 18, and 24 months. EC biomarkers will be collected at baseline. The primary aim is to determine the efficacy of a levonorgestrel-releasing intrauterine device (LNG-IUD) plus metformin, or megestrol acetate (MA) plus metformin in achieving pathological complete response (pCR) at 12 months, as well as post-treatment pregnancy outcomes and recurrence rate. The secondary aims are to predict the response to an LNG-IUD plus metformin and MA plus metformin via clinical, blood, and tissue predictive biomarkers. Conclusions Prospective evidence for conservative treatment of EC is limited. New methods to achieve better CR rates with fewer side effects are needed. This trial will investigate the effectiveness of LNG-IUD plus metformin, and MA plus metformin, in obese women with early-stage EC, providing a non-surgical treatment option for these patients. Trial registration ChiCTR2200055624. The trial was registered at http://www.chictr.org.cn/listbycreater.aspx on January 15, 2022" @default.
• W4308303217 created "2022-11-10" @default.
• W4308303217 creator A5006563800 @default.
• W4308303217 creator A5013192823 @default.
• W4308303217 creator A5023311569 @default.
• W4308303217 creator A5090613649 @default.
• W4308303217 date "2022-11-04" @default.
• W4308303217 modified "2023-10-14" @default.
• W4308303217 title "Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol" @default.
• W4308303217 cites W1841597013 @default.
• W4308303217 cites W1933506009 @default.
• W4308303217 cites W1979945461 @default.
• W4308303217 cites W1987157665 @default.
• W4308303217 cites W1987282451 @default.
• W4308303217 cites W1992662329 @default.
• W4308303217 cites W1998640066 @default.
• W4308303217 cites W2013723540 @default.
• W4308303217 cites W2026967508 @default.
• W4308303217 cites W2027055652 @default.
• W4308303217 cites W2042443221 @default.
• W4308303217 cites W2064656431 @default.
• W4308303217 cites W2067208421 @default.
• W4308303217 cites W2076879817 @default.
• W4308303217 cites W2078190084 @default.
• W4308303217 cites W2082521320 @default.
• W4308303217 cites W2088122814 @default.
• W4308303217 cites W2095427848 @default.
• W4308303217 cites W2120774442 @default.
• W4308303217 cites W2122310179 @default.
• W4308303217 cites W2129148764 @default.
• W4308303217 cites W2131644437 @default.
• W4308303217 cites W2134747962 @default.
• W4308303217 cites W2139851592 @default.
• W4308303217 cites W2148755064 @default.
• W4308303217 cites W2156100021 @default.
• W4308303217 cites W2161625420 @default.
• W4308303217 cites W2170352900 @default.
• W4308303217 cites W2173133541 @default.
• W4308303217 cites W2530872875 @default.
• W4308303217 cites W2665709303 @default.
• W4308303217 cites W2740275539 @default.
• W4308303217 cites W2742254242 @default.
• W4308303217 cites W2766744403 @default.
• W4308303217 cites W2889289499 @default.
• W4308303217 cites W2889646458 @default.
• W4308303217 cites W2891855400 @default.
• W4308303217 cites W2902570465 @default.
• W4308303217 cites W2919859489 @default.
• W4308303217 cites W3023252907 @default.
• W4308303217 cites W3043753327 @default.
• W4308303217 cites W3213382038 @default.
• W4308303217 cites W4243413044 @default.
• W4308303217 doi "https://doi.org/10.1186/s12978-022-01513-8" @default.
• W4308303217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36333773" @default.
• W4308303217 hasPublicationYear "2022" @default.
• W4308303217 type Work @default.
• W4308303217 citedByCount "3" @default.
• W4308303217 countsByYear W43083032172023 @default.
• W4308303217 crossrefType "journal-article" @default.
• W4308303217 hasAuthorship W4308303217A5006563800 @default.
• W4308303217 hasAuthorship W4308303217A5013192823 @default.
• W4308303217 hasAuthorship W4308303217A5023311569 @default.
• W4308303217 hasAuthorship W4308303217A5090613649 @default.
• W4308303217 hasBestOaLocation W43083032171 @default.
• W4308303217 hasConcept C121608353 @default.
• W4308303217 hasConcept C126322002 @default.
• W4308303217 hasConcept C126894567 @default.
• W4308303217 hasConcept C168563851 @default.
• W4308303217 hasConcept C203092338 @default.
• W4308303217 hasConcept C2776607906 @default.
• W4308303217 hasConcept C2777088508 @default.
• W4308303217 hasConcept C2777164284 @default.
• W4308303217 hasConcept C2777546739 @default.
• W4308303217 hasConcept C2777689261 @default.
• W4308303217 hasConcept C2779076696 @default.
• W4308303217 hasConcept C2779306644 @default.
• W4308303217 hasConcept C2779320873 @default.
• W4308303217 hasConcept C2780186607 @default.
• W4308303217 hasConcept C2780323712 @default.
• W4308303217 hasConcept C2780723184 @default.
• W4308303217 hasConcept C2908647359 @default.
• W4308303217 hasConcept C29456083 @default.
• W4308303217 hasConcept C2986817661 @default.
• W4308303217 hasConcept C71924100 @default.
• W4308303217 hasConcept C99454951 @default.
• W4308303217 hasConceptScore W4308303217C121608353 @default.
• W4308303217 hasConceptScore W4308303217C126322002 @default.
• W4308303217 hasConceptScore W4308303217C126894567 @default.
• W4308303217 hasConceptScore W4308303217C168563851 @default.
• W4308303217 hasConceptScore W4308303217C203092338 @default.
• W4308303217 hasConceptScore W4308303217C2776607906 @default.
• W4308303217 hasConceptScore W4308303217C2777088508 @default.
• W4308303217 hasConceptScore W4308303217C2777164284 @default.
• W4308303217 hasConceptScore W4308303217C2777546739 @default.
• W4308303217 hasConceptScore W4308303217C2777689261 @default.
• W4308303217 hasConceptScore W4308303217C2779076696 @default.
• W4308303217 hasConceptScore W4308303217C2779306644 @default.
• W4308303217 hasConceptScore W4308303217C2779320873 @default.
• W4308303217 hasConceptScore W4308303217C2780186607 @default.
• W4308303217 hasConceptScore W4308303217C2780323712 @default.

• next